BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,970 | -17.2% | 1,801 | 0.0% | 0.02% | -11.1% |
| Q2 2023 | $82,054 | -2.9% | 1,801 | -13.5% | 0.02% | -10.0% |
| Q1 2023 | $84,486 | -35.7% | 2,083 | -19.2% | 0.02% | -37.5% |
| Q4 2022 | $131,350 | -5.5% | 2,577 | 0.0% | 0.03% | -11.1% |
| Q3 2022 | $139,000 | -41.6% | 2,577 | -30.4% | 0.04% | -36.8% |
| Q2 2022 | $238,000 | -17.1% | 3,700 | 0.0% | 0.06% | 0.0% |
| Q1 2022 | $287,000 | -9.7% | 3,700 | 0.0% | 0.06% | +3.6% |
| Q4 2021 | $318,000 | +14.8% | 3,700 | +7.2% | 0.06% | +5.8% |
| Q3 2021 | $277,000 | +5.7% | 3,450 | +6.2% | 0.05% | +8.3% |
| Q2 2021 | $262,000 | +1.9% | 3,250 | +6.6% | 0.05% | -2.0% |
| Q1 2021 | $257,000 | +4.9% | 3,050 | 0.0% | 0.05% | +4.3% |
| Q4 2020 | $245,000 | -22.0% | 3,050 | -21.9% | 0.05% | -31.9% |
| Q3 2020 | $314,000 | -48.8% | 3,905 | -45.2% | 0.07% | -52.7% |
| Q2 2020 | $613,000 | +6.1% | 7,122 | 0.0% | 0.15% | -5.2% |
| Q1 2020 | $578,000 | -4.3% | 7,122 | -1.4% | 0.15% | +21.3% |
| Q4 2019 | $604,000 | -4.4% | 7,222 | 0.0% | 0.13% | -13.6% |
| Q3 2019 | $632,000 | +6.9% | 7,222 | 0.0% | 0.15% | +10.5% |
| Q2 2019 | $591,000 | +2.1% | 7,222 | +1.4% | 0.13% | 0.0% |
| Q1 2019 | $579,000 | +23.5% | 7,122 | 0.0% | 0.13% | +5.6% |
| Q4 2018 | $469,000 | -14.6% | 7,122 | 0.0% | 0.13% | +0.8% |
| Q3 2018 | $549,000 | +6.0% | 7,122 | +1.4% | 0.12% | -2.3% |
| Q2 2018 | $518,000 | +13.3% | 7,022 | 0.0% | 0.13% | +10.3% |
| Q1 2018 | $457,000 | -8.6% | 7,022 | -9.2% | 0.12% | -10.1% |
| Q4 2017 | $500,000 | +3.1% | 7,733 | 0.0% | 0.13% | -12.2% |
| Q3 2017 | $485,000 | +3.6% | 7,733 | -0.1% | 0.15% | +0.7% |
| Q2 2017 | $468,000 | +13.6% | 7,742 | -2.8% | 0.15% | +13.2% |
| Q1 2017 | $412,000 | +21.5% | 7,962 | +3.9% | 0.13% | +14.2% |
| Q4 2016 | $339,000 | +66.2% | 7,662 | +78.4% | 0.11% | +59.2% |
| Q3 2016 | $204,000 | +10.3% | 4,295 | +4.9% | 0.07% | +7.6% |
| Q2 2016 | $185,000 | +10.1% | 4,095 | 0.0% | 0.07% | +6.5% |
| Q1 2016 | $168,000 | +3.1% | 4,095 | -3.9% | 0.06% | +1.6% |
| Q4 2015 | $163,000 | +16.4% | 4,260 | 0.0% | 0.06% | +13.0% |
| Q3 2015 | $140,000 | -53.0% | 4,260 | 0.0% | 0.05% | -48.1% |
| Q2 2015 | $298,000 | +2.1% | 4,260 | 0.0% | 0.10% | +8.3% |
| Q1 2015 | $292,000 | -6.7% | 4,260 | 0.0% | 0.10% | -6.8% |
| Q4 2014 | $313,000 | +7.9% | 4,260 | +5.4% | 0.10% | +4.0% |
| Q3 2014 | $290,000 | +5.1% | 4,040 | +5.8% | 0.10% | +11.2% |
| Q2 2014 | $276,000 | -1.8% | 3,820 | 0.0% | 0.09% | -10.1% |
| Q1 2014 | $281,000 | +2.2% | 3,820 | -3.2% | 0.10% | 0.0% |
| Q4 2013 | $275,000 | -10.1% | 3,945 | -15.1% | 0.10% | -20.2% |
| Q3 2013 | $306,000 | -12.6% | 4,645 | -7.9% | 0.12% | -7.5% |
| Q2 2013 | $350,000 | – | 5,045 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |